Drug Trial Radar · NCT02348632
"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
Last checked: Nov 20, 2026Latest source record: Jun 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
645
Actual
Start
May 2015
Primary completion
Dec 2017
Study completion Dec 2017
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- Jan 28, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3 study to assess the long-term safety and maintenance of efficacy of JZP-110 in subjects who have completed Study 14-002, 14-003, 14-004, 15-004, 15-005, ADX-N05 201, or ADX-N05 202.
Conditions
- Narcolepsy
- Obstructive Sleep Apnea
Interventions
JZP-110Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Epworth Sleepiness Scale (ESS) ScoreTime frame: Start of randomized withdrawal phase to end of randomized withdrawal (2 weeks)
Locations
80 sites in 6 countries. Site status is shown where the registry gives one.
Sleep Disorders Center of Alabama
Birmingham, Alabama
Pulmonary Associates
Glendale, Arizona
Mayo Clinic in Arizona
Scottsdale, Arizona
Preferred Research Partners
Little Rock, Arkansas
UC San Diego Medical Center
La Jolla, California
So Cal Institute For Respiratory Diseases, Inc.
Los Angeles, California
Pacific Sleep Medicine
Oceanside, California
The Research Center of Southern California
Oceanside, California
Stanford University Center for Narcolepsy
Redwood City, California
Pacific Research Network Inc.
San Diego, California
VA San Diego Healthcare System
San Diego, California
Santa Monica Clinical Trials
Santa Monica, California
Critical care Pulmonary & Sleep Associates, LLC
Lakewood, Colorado
MD Clinical
Hallandale, Florida
Oviedo Medical Research, LLC
Oviedo, Florida
Clinical Research Group of St. Petersburg
St. Petersburg, Florida
Florida Pediatric Research Institute
Winter Park, Florida
Emory Sleep Center
Atlanta, Georgia
NeuroTrials Research Inc.
Atlanta, Georgia
SleepMed of Central Georgia
Macon, Georgia
Northwestern University Feinberg School of Medicine
Chicago, Illinois
University of Illinois at Chicago Nursing School
Chicago, Illinois
Rowe Neurology Institute RNI - Lenexa
Lenexa, Kansas
Veritas Clinical Specialties LTD
Topeka, Kansas
Kentucky Research Group
Louisville, Kentucky
Advanced Neurodiagnostic Center
Metairie, Louisiana
Johns Hopkins Hospital
Baltimore, Maryland
The Center for Sleep & Wake Disorders
Chevy Chase, Maryland
Brigham and Women's Hospital
Boston, Massachusetts
Neurocare, Inc.
Newton, Massachusetts
Henry Ford Hospital Sleep Disorders & Research Center
Detroit, Michigan
Clinical Neurophysiology Services
Sterling Heights, Michigan
Minnesota Lung Center
Edina, Minnesota
Sleep Medicine & Research center, St. Lukes Hospital
Chesterfield, Missouri
University of Missouri
Columbia, Missouri
Clayton Sleep Institute
St Louis, Missouri
New York University Medical Center
New York, New York
Clinilabs
New York, New York
Montefiore Medical Center
The Bronx, New York
Duke University Medical Center
Durham, North Carolina
Showing 40 of 80 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.